2001
DOI: 10.1067/msy.2001.111699
|View full text |Cite
|
Sign up to set email alerts
|

Application of sentinel node biopsy to gastric cancer surgery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

7
166
0
20

Year Published

2003
2003
2012
2012

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 253 publications
(193 citation statements)
references
References 20 publications
7
166
0
20
Order By: Relevance
“…In this experiment the identification and classification of the blue and/or radioactive lymph node occurred just before and/or during exeresis of the organs, although this procedure is recommended before the gastrectomy, at varied times, according to the characteristics of the dye used 5,10,12,[15][16][17][21][22][23] .…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…In this experiment the identification and classification of the blue and/or radioactive lymph node occurred just before and/or during exeresis of the organs, although this procedure is recommended before the gastrectomy, at varied times, according to the characteristics of the dye used 5,10,12,[15][16][17][21][22][23] .…”
Section: Discussionmentioning
confidence: 99%
“…In the last decade, SLNB has also been carried out for cases of early gastric cancer 5,[8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27] .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…A partir do final dos anos 90, encontramos muitos relatos que evidenciaram este fato [1][2][3][4][5][6][7][8][9][10][11][12][13][14] .…”
Section: Introductionunclassified
“…2007; 34(6): 367-373 Os três métodos para se realizar a pesquisa do linfonodo sentinela em câncer gástrico utilizam: o corante isolado, o radiotraçador isolado e a combinação de ambos 11,13 . A principal indicação para pesquisa do linfonodo sentinela em câncer gástrico parece ser em tumores precoces T1, devido às baixas probabilidades de metástases para linfonodos 5,[15][16][17][18] . No entanto, nenhuma publicação relata restrição do seu uso em tumores avançados (T2,T3), apenas deve-se ter idéia de que quanto maior o grau de invasão tumoral maiores as chances de casos com LFNsn falso negativo 12 .…”
unclassified